Securities fraud litigation history and active cases
In Litigation
1
Settlement
0
Closed
1
Total Settlement
$2.25M
26-1958 • January 7, 2025
Class Period Start
September 26, 2024
Class Period End
January 7, 2025
PSLRA Deadline
March 10, 2025
Case Allegations
Sec11
Statutes of Repose
Sep 26, 2027
Country
United States
Court
Federal Court
Mar 31, 2026
Mar 2, 2026
The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.
Dec 22, 2025
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Nov 20, 2025
A new complaint has been filed on behalf of certain investors in BioAge Labs, Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Oct 30, 2025
The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.
2:17cv1531 • March 18, 2017
Class Period Start
July 14, 2014
Class Period End
August 3, 2017
PSLRA Deadline
May 17, 2017
Case Allegations
10b5
Statutes of Repose
Jul 14, 2017
Country
United States
Court
Federal Court
Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.
Claim Deadline
April 22, 2020
Settlement Fund
$2,250,000
Settlement Status
Disbursed
Settlement Class
All persons or entities that purchased, otherwise acquired or sold the common stock (CUSIP: 09072Q106) or warrants (CUSIP: 09072Q114) of BioAmber, Inc. (“BioAmber” or the “Company”), except those purchased or sold on the Toronto Stock Exchange, between July 15, 2014 and August 3, 2017, both dates inclusive.
Claim Administrator
Strategic Claims Services
BioAmber, Inc. Securities Litigation
c/o Strategic Claims Services
600 N. Jackson St., Ste. 205
P.O. Box 230 Media, PA 19063
+1 866-274-4004
[email protected]
Settlement Website
https://www.strategicclaims.net/bioamber/Hearing Date
May 20, 2020
Opt-out Deadline
April 29, 2020
Settlement Note
Download hereProof Of Claim
Download here
Jun 15, 2022
Disbursement Approved
The court has approved the distribution of settlement funds to eligible class members. Investors with approved claims may receive payments from the settlement. If you have questions about your claim or payment, contact the claims administrator.
Dec 14, 2020
Final Approval of Settlement
The court has granted final approval of the settlement. Eligible investors who submit valid claims may receive a payment once the claims review and distribution process is completed.
Jan 14, 2020
Preliminary Approval of Settlement
The court has granted preliminary approval of a proposed settlement. This means the settlement can move forward for further consideration, but it has not yet received final approval. Potential class members will generally receive notice explaining the settlement, their rights, and any deadlines for submitting a claim, objecting to the settlement, or choosing not to participate.
Jan 14, 2020
Proof of Claim Form
To receive your portion of the recovery (if you are eligible), you must submit this form to the claims administrator by the deadline indicated on the form itself. If you do not submit this form in time, you will not be entitled to compensation. If you have questions about how to complete the form, you should contact the claims administrator.
Oct 6, 2017
Motion to Dismiss
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
TOP
